The fetal insulin hypothesis: An alternative explanation of the association of low birthweight with diabetes and vascular disease

Lancet

Volumn 353, Issue 9166, 1999, Pages 1789-1792

  Hattersley, Andrew T ^a   Tooke, John E ^a  

^a School of Postgraduate Medicine and Health Sciences   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FETUS; FETUS DEVELOPMENT; FETUS GROWTH; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; LOW BIRTH WEIGHT; MALNUTRITION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RISK; VASCULAR DISEASE;

EID: 0033594787     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)07546-1     Document Type: Note

References (43)

1. Barker DJP, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. BMJ 1990; 301: 259-62.
2. Barker DJP, Godfrey KM, Osmond C, Bull A. The relation of fetal length, ponderal index and head circumference to blood pressure and the risk of hypertension in adult life. Paediatr Perinat Epidemiol 1992; 6: 35-44.
3. Hales CN, Barker DJP, Clark PMS, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 1991; 303: 1019-22.
4. Phipps K, Barker DJ, Hales CH, Fall CH, Osmond C, Clark PM. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993; 36: 225-28.
5. Yajnik CS, Fall CH, Vaidya U, et al. Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabet Med 1995; 12: 330-36.
6. Law CM, Gordon GS, Shiell AW, Barker DJ, Hales CN. Thinness at birth and glucose tolerance in seven-year-old children. Diabet Med 1995; 12: 24-29.
7. Clausen JO, Borch-Johnsen K, et al. Relation between birth weight and the insulin sensitivity index in a population sample of 331 young, healthy Caucasians. Am J Epidemiol 1997; 146: 23-31.
8. Hales CN. The pathogenesis of NIDDM. Diabetologia 1994; 37 (suppl 2): S162-68.
9. Barker DJ. Intrauterine programming of adult disease. Mol Med Today 1995; 1: 418-23.
10. Pederson J. Hyperglycaemia-hyperinsulinism theory and birthweight. In: The pregnant diabetic and her new born: problems and management. Baltimore: Williams & Wilkins, 1977: 211-20.
11. Naylor CD, Sermer M, Chen E, Sykora K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators. JAMA 1996; 275: 1165-70.
12. Tallarigo L, Giampietro O, Genno G, Miccoli R, Gregori G, Navalesi R. Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med 1986; 315: 989-92.
13. Farmer G, Russell G, Hamilton-Nicol DR, et al. The influence of maternal glucose metabolism on fetal growth, development and morbidity in 917 singleton pregnancies in nondiabetic women. Diabetologia 1988; 31: 134-41.
14. Breshi MC, Seghieri G, Bartolomei G, Gironi A, Baldi S, Ferrannini E. Relation of birth weight to maternal plasma glucose and insulin concentrations during normal pregnancy. Diabetologia 1993; 36: 1315-21.
15. Sermer N, Naylor CD, Gare DJ, et al. Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes: the Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 1995; 173: 146-56.
16. Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 1993; 328: 697-702.
17. Byrne MM, Sturis J, Clement K, et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 1994; 93: 1120-30.
18. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 1998; 19: 268-70.
19. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotidedeletion in the human IPF1 gene coding sequence. Nat Genet 1997; 15: 106-10.
20. Wright NM, Metzger DL, Borowitz SM, Clarke WL. Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis. Am J Dis Child 1993; 147: 607-09.
21. Temple IK, James RS, Crolla JA, et al. An imprinted gene(s) for diabetes? Nat Genet 1995; 9: 110-12.
22. Temple IK, Gardner RJ, Robinson DO, et al. Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-q23. Hum Mol Genet 1996; 5: 1117-24.
23. Shield JPH. Neonatal diabetes. In: Shield JPH, Baum JD, eds. Childhood diabetes. London: Baillière Tindall, 1996: 681-740.
24. Thomas PM, Cote GJ, Wohllk K, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268: 426-29.
25. Thomas P, Ye Y, Lightner E. Mutation of the pancreatic islet inward rectifier Kir6·2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 1996; 5: 1809-12.
26. Aparicio L, Carpenter MW, Schwartz R, Gruppuso PA. Prenatal diagnosis of familial neonatal hyperinsulinemia. Acta Paediatr 1993; 83: 683-86.
27. Elsas LJ, Endo F, Strumlauf E, Elders J, Priest JH, Leprechaunism: an inherited defect in a high-affinity insulin receptor. Am J Hum Genet 1985; 37: 73-88.
28. Donohue WL, Uchida IA. Leprechaunism: a euphenism for a rare familial disorder. J Pediatr 1954; 45: 505-19.
29. Matschinsky F, Liang Y, Kesavan P, et al. Glucokinase as pancreatic beta cell glucose sensor and diabetes gene. J Clin Invest 1993; 92: 2092-98.
30. Hattersley AT. Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 1998; 15: 15-24.
31. Hseuh WA, Quinones MJ, Creager MA. Endothelium in insulin resistance and diabetes. Diabet Rev 1997; 5: 343-52.
32. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172-79.
33. Hudlicka O, Brown M, Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992; 72: 369-471.
34. Feener EP, King GL. Vascular dysfunction in diabetes mellitus. Lancet 1997; 350 (suppl 1): S19-13.
35. Noon JP, Walker BR, Webb DJ, et al. Impaired microvascular dilatation and capllary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest 1997; 99: 1873-79.
36. Serné EH, Stehouwer CDA, ter Maaten JC, Donker AJM, Gans ROB. Insulin resistance and hypertension: role for microcirculation? Diabetologia 1997; 40 (suppl 1): A256 (abstr).
37. Chapman N, Monhamudally A, Cerutti A, et al. Retinal vascular network architecture in low-birth-weight men. J Hypertens 1997; 15: 1449-53.
38. Law CM, Barker DJ, Osmond C, Fall CH, Simmonds SJ. Early growth and abdominal fatness in adult life. J Epidemiol Community Health 1992; 46: 184-86.
39. van der Poll T, van Deventer SJH, Pasterkamp G, van Mourik JA, Büller HA, ten Cate JW. Tumour necrosis factor induces von Willebrand factor release in healthy humans. Thromb Haemost 1992; 67: 623-26.
40. Kroder G, Bossenmaier B, Kellerer M, et al. Tumor necrosis factor-α- and hyperglycemia-induced insulin resistance. J Clin Invest 1996; 97: 1471-77.
41. Shimomura I, Funahashi T, Takahashi M, et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996; 2: 800-03.
42. Phillips DI, McLeish R, Osmond C, Hales CN. Fetal growth and insulin resistance in adult life: role of plasma triglyceride and non-esterified fatty acids. Diabet Med 1995; 12: 796-801.
43. Sherman RC, Langley-Evans C. Early administration of angiotensin-converting enzyme inhibitor captopril, prevents the development of hypertension. Clin Sci 1998; 94: 373-81.